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BACKGROUND: Proinflammatory cytokine levels may be associated with cancer stage, recurrence, and survival. The objective of this
study was to determine whether cytokine levels were associated with dietary patterns and fat-soluble micronutrients in patients with
previously untreated head and neck squamous cell carcinoma (HNSCC). METHODS: This was a cross-sectional study of 160 patients
with newly diagnosed HNSCC who completed pretreatment food frequency questionnaires (FFQs) and health surveys. Dietary pat-
terns were derived from FFQs using principal component analysis. Pretreatment serum levels of the proinflammatory cytokines
interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-a), and interferon gamma (IFN-g) were measured using an enzyme-linked im-
munosorbent assay, and serum carotenoid and tocopherol levels were measured by high-performance liquid chromatography. Multi-
variable ordinal logistic regression models examined associations between cytokines and quartiles of reported and serum dietary
variables. RESULTS: Three dietary patterns emerged: whole foods, Western, and convenience foods. In multivariable analyses, higher
whole foods pattern scores were significantly associated with lower levels of IL-6, TNF-a, and IFN-g (P.001, P5.008, and P5.03,
respectively). Significant inverse associations were reported between IL-6, TNF-a, and IFN-g levels and quartiles of total reported
carotenoid intake (P5.006, P5.04, and P5.04, respectively). There was an inverse association between IFN-g levels and serum
a-tocopherol levels (P5.03). CONCLUSIONS: Consuming a pretreatment diet rich in vegetables, fruit, fish, poultry, and whole grains
may be associated with lower proinflammatory cytokine levels in patients with HNSCC. Cancer 2014;120:2704-12. VC 2014 American
Cancer Society.
KEYWORDS: dietary patterns, carotenoids, cytokines, head and neck cancer.
INTRODUCTION
Higher fruit and vegetable intake and levels of serum carotenoids are associated with more favorable prognoses in patients
with head and neck squamous cell carcinoma (HNSCC).1-4 We previously reported that a whole foods pattern, character-
ized by high intakes of vegetables, fruits, whole grains, poultry, and fish, and a body mass index (BMI) 25 kg/m2 at the
time of diagnosis were associated with lower recurrence and mortality rates in a large, prospective cohort of patients with
newly diagnosed HNSCC.5 These findings suggest diet as a potential area of intervention to improve HNSCC prognosis.
However, research exploring the potential mechanisms underlying these associations is warranted to deepen our understand-
ing of how nutritional interventions may influence patient survival.
It is widely accepted that chronic inflammation can be a driver of cancer development and progression.6 The proin-
flammatory cytokines interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-a) are mediators of the immune response
and are thought to be involved in malignant transformation, progression, and prognosis.6 It has been demonstrated that en-
dothelial cells in the tumor microenvironment, and HNSCC cells themselves, secrete high levels of IL-6, inducing tumor
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invasion and metastasis.7,8 In observational studies, higher
IL-6 has been associated with later cancer stage,9-11 and IL-
612-15 and TNF-a16 have been associated with increased
HNSCC recurrence and mortality, including within our
ownHNSCC study population.17,18
Dietary intake is known to be involved in the physi-
ologic response to inflammation and oxidative stress.19
Therefore, we hypothesize that foods and nutrients with
antioxidant and anti-inflammatory properties such as
carotenoids and vitamin E may mitigate the effects of
proinflammatory cytokines in the body, reducing the like-
lihood of metastasis and prolonging survival. To our
knowledge, the relationship between diet and cytokines
has not been studied in HNSCC. The objective of this
study was to examine associations of dietary patterns, car-
otenoids, and tocopherols with pretreatment serum levels
of proinflammatory cytokines in a cohort of patients with
newly diagnosed HNSCC.
MATERIALS AND METHODS
Design, Setting, and Patients
This was a cross-sectional study of patients newly diag-
nosed with HNSCC and enrolled in the University of
Michigan Head and Neck Specialized Program of
Research Excellence (HN-SPORE). Institutional Review
Board approval was granted from the University of Michi-
gan Health System (Ann Arbor, Mich). Patients were
recruited between November 2008 and November 2012.
Exclusion criteria included: 1) age<18 years, 2) pregnant,
3) non-English speaking, 4) diagnosed as mentally unsta-
ble, 5) diagnosis of another nonupper aerodigestive tract
cancer, or 6) any head and neck primary diagnosed within
the past 5 years.
Participants completed a self-administered health
questionnaire before treatment that collected data on
demographics, tobacco use, alcohol use, weight status,
and comorbidities. Pretreatment dietary intake was
assessed using the 2007 self-administered, semiquantita-
tive Harvard Food Frequency Questionnaire (FFQ).20
Medical records were reviewed to collect data on tumor
site and stage.
Peripheral blood samples (30 mL) were collected
before treatment using routine venipuncture technique.
Sera were collected after centrifugation of blood and
stored in 0.5-mL aliquots at 280C until testing. To
ensure patient confidentiality and blind laboratory per-
sonnel, all serum samples were immediately barcoded and
assigned a numerical identifier before being stored in the
HN-SPORE Tissue Core.
Measures
Reported diet
The validated 2007 Harvard FFQ was designed to assess
respondents’ usual dietary intake from food and supple-
ments over the past year.21-23 The FFQ includes standard
portion sizes for each item and allows participants to
choose their average frequency of consumption over the
past year. Total energy and nutrient intakes were esti-
mated by summing intakes from each food based on the
portion size, frequency of consumption, and nutrient con-
tent of each food. Daily food servings were estimated by
summing the frequency weights of each food item based
on reported daily frequencies of consumption.23
Serum micronutrients
Serum carotenoids and tocopherols were extracted and
analyzed using high-performance liquid chromatography
(HPLC) as previously described.24 Briefly, serum was
mixed with an equal volume of ethanol containing buty-
lated hydroxytoluene and extracted with hexane. Tocol
was used as the internal standard. A YMC C30 reverse-
phase column (23 150 mm with a 2.03 20 mm guard)
was used to separate carotenoids and tocopherols (YMC
Company, LTD, Kyoto, Japan) using gradient elution at
0.2 mL per minute total flow on a Shimadzu LC-20AT
HPLC system (Shimadzu Corporation, Kyoto, Japan).
Detection was at 450 to 472 nm for carotenoids. Electro-
chemical detection was used for Tocol and tocopherols
with a Coularray electrochemical detector set (Thermo
Scientific, Waltham, Mass) at 310, 390 and 470 mV.
Samples were analyzed in 6 batches of approximately 30
samples per batch.
Covariates
Sociodemographic variables were age, sex, and education
level. The highest educational level attained was dicho-
tomized as high school diploma or equivalent and some
college or more. Smoking data were categorized as current,
former, or never smoker, where the status current reflects
use in the 12 months before cancer diagnosis. Alcohol
abuse was measured using the previously validated Alco-
hol Use Disorders Identification Test (AUDIT).25 An
AUDIT score 8 was considered problem drinking. Tu-
mor site was recorded from medical records and catego-
rized into 3 groups: 1) oral cavity, 2) oropharynx, and 3)
larynx. To increase the statistical power of stage-wise com-
parisons, cancer stage was categorized a priori into 3
groups, with stages I and II collapsed, and stages III and
IV considered separately. Tumor human papillomavirus
(HPV)-status was determined by an ultrasensitive method
Diet and Cytokines in HNSCC/Arthur et al
Cancer September 1, 2014 2705
using real-time, competitive polymerase chain reaction
and matrix-assisted laser desorption/ionization time-of-
flight mass spectroscopy with separation of products on a
matrix-loaded silicon chip array as previously described.26
Comorbidities were recorded using the Adult Comorbid-
ity Evaluation-27 instrument and were categorized into
none or mild comorbidities compared with moderate to
severe comorbidities.27
Serum cytokines
Cytokine levels were determined using standard method-
ology established in our Cancer Center ImmuneMonitor-
ing Core using commercially available, paired-antibody
enzyme-linked immunosorbent assay kits. All blood sam-
ples were obtained in the outpatient clinic and were stored
at 4C until they were transferred to the Tissue Core
(within 2 hours), where they were immediately centri-
fuged, and the sera were separated into 2-lL aliquots and
frozen immediately for storage at 280C. Internal con-
trols were used for all enzyme-linked immunosorbent
assay plates, and all patient samples were assayed in the
same batch, because the microplate arrays for analysis
accommodated 174 duplicate samples at a time. Briefly,
serum sample aliquots frozen at280C were thawed and
then incubated overnight at 4C in duplicate (25 lL per
well) on microtiter plates precoated with monoclonal
antibody specific for IL-6, TNF-a, or interferon gamma
(IFN-g). Any unbound substances were washed away,
and biotin-linked polyclonal antibody specific for the
cytokine was introduced. After incubation for 2 hours at
room temperature, the plates were washed and incubated
with streptavidin-horseradish peroxidase for an additional
hour. After a final wash, substrate solution was added, and
color development was stopped after 25 minutes at room
temperature. A microplate reader was then used to deter-
mine colorimetric densities for each sample as calculated
from a standard curve. The test sensitivity was determined
per manufacturer guidelines. For quality control, multiple
plasma aliquots from a single donor were prepared, and 1
aliquot was analyzed with the batch of samples. Frozen ali-
quots were stored for repetitive testing if necessary.
Statistical Analysis
Descriptive statistics (means and frequencies) were gener-
ated for all demographic, epidemiologic, and clinical vari-
ables. Dietary intake data were assessed for missing values
and energy outliers using the Rosner method.23,28 Food
consumption data from FFQs were classified a priori into
40 foods and food groups using methods similar to those
described in previous studies of dietary patterns and dis-
ease,29,30 and pretreatment dietary patterns were derived
by using principal component analysis (PCA), as previ-
ously reported.5 PCA is a data-reduction method that
derives dietary patterns by aggregating food variables to-
gether for which the intakes are correlated.31 Pattern fac-
tor scores were calculated for each study participant and
were categorized into quartiles for analysis with serum
cytokine levels.
Odds ratios (ORs) and associated 95% confidence
intervals (CIs) were calculated from multivariable logistic
regression models to assess the relationships between die-
tary variables and cytokine levels. Cytokine values were
categorized into 2 or 3 levels according to their observed
empirical count distribution. IFN-g and IL-6 were cate-
gorized into 3 levels: zero level, nonzero low level, and
nonzero high level, in which the medians of the nonzero
values were used to separate the latter 2 levels. TNF-a was
dichotomized into zero and nonzero levels because of the
high proportion of zero values (64%). For the outcomes
with 3 levels, an ordinal logistic model with the propor-
tional odds assumption was used.32 When possible, the
proportional odds assumption was imposed (ie, we
assumed that the ORs between any 2 neighboring catego-
ries were the same). This allowed us to achieve more effi-
cient estimation, especially given the small sample size.
Dietary pattern scores and carotenoid and tocopherol lev-
els were categorized into quartiles for use in statistical
models. Cochran-Armitage tests for linear trend across
quartiles were conducted between cytokines and nutrient
quartiles.33 All final models were adjusted for age, sex, tu-
mor site, cancer stage, smoking, and alcohol problem.
Education, BMI, and Adult Comorbidity Evaluation-27
scores were considered as covariates but were excluded
from the final models. Stratified analyses were conducted
in which associations were examined separately for
patients with stage I, II, or III cancers and patients with
stage IV cancers to assess potential effect modification by
cancer stage. To examine HPV status as a potential con-
founder, analyses were repeated in the subset of 122
patients who had HPV status available. The SAS statistical
software package (version 9.3; SAS Institute Inc., Cary,
NC) was used for all analyses. P values< .05 were consid-
ered statistically significant, and no multiplicity adjust-
ments were performed.
RESULTS
Of 737 eligible patients approached, 670 consented to
participate, yielding a response rate of 91%. Additional
patients were excluded who did not complete a baseline
FFQ (n5 304), withdrew from the study (n5 24), had
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reported daily energy intake <200 or >5000 kilocalories
(kcals) per day (n5 6), or did not have baseline serum lev-
els available for use in the study (n5 175). The final sam-
ple size included 160 patients with newly diagnosed
HNSCC.
Characteristics of the study population are listed in
Table 1. The mean age of study participants was approxi-
mately 60 years. The majority of participants were white
(94.4%) and were men (80.1%). Approximately 60% of
the participants had at least some college education. The
most frequent tumor location was the oropharynx
(47.8%), and most participants presented to University of
Michigan Health System clinics with late-stage (III or IV)
cancers (84.9%). About 74% of participants were ever
smokers, and<20% reported an alcohol problem (16.2%
had AUDIT scores8). The mean BMI at the time of di-
agnosis was 27.2 kg/m2, which is considered overweight
but lower than the average BMI of 28.7 kg/m2 in the US
population from 1999 to 2010.34 Of the 122 patients
who had tumor HPV status available, 61.5% were posi-
tive, and 38.5% were negative. Correlations between se-
rum and reported antioxidants are displayed in Table 2.
Mean cytokine levels by patient characteristics are
reported in Table 3.
Three major dietary patterns emerged from PCA.
The first pattern, termed the whole foods pattern, was char-
acterized by high intakes of vegetables, fruits, legumes,
fish, poultry, fruit juice, water, and wine and low intakes
of sugar-sweetened beverages and beer. The second pat-
tern, termed the Western pattern, was characterized by
high intakes of red and processed meats, refined grains,
condiments, eggs, coffee, butter, and high-fat dairy and
low intakes of fruits, legumes, and cereals. The third pat-
tern, termed the convenience foods pattern, was character-
ized by high intakes of cereals, pizza, desserts, diet
beverages, and energy bars and low intakes of other vege-
tables and beer.
Levels of IL-6, TNF-a, and IFN-g decreased signifi-
cantly across increasing quartiles of whole foods pattern
score (Table 4). IL-6, TNF-a, and IFN-g levels also had a
significant, inverse association with total reported carote-
noid intake. Significant inverse associations were observed
across increasing quartiles of lycopene intake for IL-6 and
total vitamin E intake for IFN-g. No significant associa-
tions were reported between IL-6 and TNF-a and serum
carotenoids (Table 5). There was a significant trend to-
ward decreased IFN-g levels across increasing quartiles of
serum a-tocopherol and b-cryptoxanthin levels. The
results did not differ significantly when stratified by can-
cer stage or when analyses were performed that included
HPV status as a covariate for the subset of 122 patients
who had HPV status available.
DISCUSSION
High whole foods dietary pattern scores and reported
intake of total carotenoids before treatment were associated
with significantly lower serum levels of the proinflamma-
tory cytokines IL-6, TNF-a, and IFN-g, independent of
other factors known from previous research to modulate
cytokine levels.35 In addition, higher reported intake of ly-
copene was significantly associated with lower IL-6 levels,
and higher reported vitamin E intake and serum
a-tocopherol levels were associated with lower IFN-g
levels.
To our knowledge, this is the first study to examine
the correlation of dietary patterns and carotenoids with se-
rum proinflammatory cytokine levels in patients with
HNSCC. Our results support findings from prior
TABLE 1. Pretreatment Characteristics of Patients
With Newly Diagnosed Head and Neck Cancer
(n5 160)
Characteristic No. of Patients (%)
Age: Mean6SD [range], y 59.7 610.7 [25-93]
Sex
Men 128 (80)
Women 32 (20)
Race
White/non-Hispanic 151 (94.4)
Non-white/Hispanic 9 (5.6)
Education
High school 63 (39.4)
Some college 97 (60.6)
Site
Oral cavity 48 (30)
Oropharynx 77 (48.1)
Larynx 35 (21.9)
Stage
I, II 25 (15.6)
III 24 (15)
IV 111 (69.4)
HPV statusa
Positive 47 (38.5)
Negative 75 (61.5)
ACE-27 comorbidity score
None or mild 114 (71.2)
Moderate or severe 46 (28.8)
Smoking status
Current 25 (15.6)
Former 93 (58.1)
Never 42 (26.3)
Alcohol problem: AUDIT score 8
Yes 26 (16.2)
No 134 (83.8)
BMI: Mean 6SD, [range] kg/m2 27.265.5 [13.1-54.4]
Abbreviations: ACE-27, Adult Comorbidity Evaluation-27; AUDIT, Alcohol
Use Disorders Identification Test; BMI, body mass index; HPV, human pap-
illomavirus; SD, standard deviation.
a HPV status was available for 122 study participants.
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research examining this correlation in other study popula-
tions. In a prospective analysis conducted among a popu-
lation of older adults as part of the Health ABC Study, a
healthy dietary pattern (consistent with our whole foods
dietary pattern) was associated with lower IL-6 levels than
a dietary pattern high in sweets and high-fat dairy prod-
ucts.36 An intervention trial conducted among men with
metabolic syndrome indicated that those randomized to a
Mediterranean diet, which was rich in the foods character-
istic of our whole foods dietary pattern, had significantly
lower IL-6 and TNF-a levels after 5 weeks compared with
the control group.37
Our current results demonstrate a statistically signif-
icant, inverse association between IL-6 levels and reported
total carotenoids. Similarly, higher serum concentrations
of total carotenoids were correlated with lower IL-6 and
TNF-a levels in patients who had recent hip fractures.38
In contrast, a case-control study of breast cancer risk indi-
cated no association between IL-6 levels and reported
intake of b-carotene.39 Low a-tocopherol plasma concen-
trations were associated with increased expression of the
gene encoding IFN-g in another study conducted among
patients with breast cancer.40 These results are consistent
with our findings that high reported intake of total vita-
min E and serum levels of a-tocopherol were associated
with lower levels of IFN-g in patients with HNSCC.
One mechanism by which the whole foods dietary
pattern, carotenoids, and tocopherols may help to
TABLE 2. Spearman Correlations Between
Food Frequency Questionnaire-Reported and
Serum-Measured Nutrients (n5 160)
Nutrient
Correlation
Coefficient P
Total carotenoids 0.24 .004a
a-Carotene 0.29 <.001a
b-Carotene 0.30 <.001a
Lycopene 0.10 .21
b-Cryptoxanthin 0.38 <.001a
Lutein 0.97 <.001a
Zeaxanthin 0.87 <.001a
a-Tocopherol 0.27 <.001a
g-Tocopherol 0.02 .78
aP values< .05 indicate a significant difference.
TABLE 3. Mean and Standard Deviation Cytokine Levels (pg/ml) by Patient Characteristics (n5 160)
Mean6SD
Characteristic No. of Patients IL-6 TNF-a IFN-g
Sex
Men 128 118.76 448.5 187.96 785.2 538.46 838.5
Women 32 17.16 66.8 15.96 74.7 359.36 789.8
Race
White/non-Hispanic 151 103.46 415.4 162.56 725.8 508.36 834.8
Non-white/Hispanic 9 14.06 15.9 2.16 6.3 407.06 777.6
Education
High school 63 82.16 399.6 145.86 709.5 404.66 767.1
Some college 97 108.96 408.5 158.56 707.2 566.26 865.9
Site
Oral cavity 48 73.66 261.8 85.16 311.3 459.56 787.7
Oropharynx 77 134.96 538.1 222.66 964.1 570.56 910.5
Larynx 35 52.16 122.6 95.26 312.5 412.26 697.9
Stage
I, II 25 129.96 360.8 158.66 426.9 407.96 717.9
III 24 46.46 67.3 63.96 126.4 641.06 946.8
IV 111 102.56 453.6 171.76 821.6 493.96 829.9
HPV statusa
Positive 47 126.96 523.5 188.56 845.5 675.16 955.0
Negative 75 69.26 223.7 98.26 326.5 470.96 774.6
Smoking status
Current 25 21.96 48.5 31.76 105.7 356.26 735.1
Former 93 37.46 85.3 55.26 197.3 402.06 696.9
Never 42 278.86 754.9 443.66 1312.1 812.36 1062.6
Alcohol problem: AUDIT score 8
Yes 26 26.86 52.1 34.06 105.0 315.76 677.1
No 134 112.36 439.8 176.76 768.3 538.86 853.6
Abbreviations: AUDIT, Alcohol Use Disorders Identification Test; HPV, human papillomavirus; IFN-g, interferon gamma; IL-6, interleukin-6; SD, standard devia-
tion; TNF-a, tumor necrosis factor alpha.
a HPV status was available for 122 study participants.
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reduce circulating cytokine levels in patients with
HNSCC is through modulation of the nuclear factor-
kappaB (NF-jB) pathway. Several epidemiologic and
clinical studies have implicated NF-jB as a driver of
cancer progression, indicating that this pathway is a
potential target for therapeutic intervention.41 IL-6,
TNF-a, and IFN-g all can stimulate the NF-jB path-
way.41,42 It also has been reported that oxidative stress
activates the NF-jB family of transcription factors, fur-
ther up-regulating the expression of proinflammatory
cytokines.39,43 Nutrients that can reduce oxidative stress
and inflammation in the body such as carotenoids and
tocopherols—both of which are abundant in foods that
characterize the whole foods dietary pattern—have
demonstrated the ability to suppress NF-jB in labora-
tory studies.44
We observed several significant associations between
reported dietary variables and cytokine levels but did not
TABLE 4. Multivariable Odds Ratios and 95% Confidence Intervals for Proinflammatory Cytokine Levels by
Quartile of Food Frequency Questionnaire-Reported Dietary Patterns and Nutrient Intake (n5 160)a
IL-6: OR (95% CI)b
Pattern/Nutrient Intake Q2 Q3 Q4 Ptrend
Whole foods pattern 0.41 (0.16-1.04) 0.32 (0.12-0.86) 0.16 (0.06-0.45) < .001c
Western pattern 1.19 (0.49-2.87) 0.48 (0.19-1.22) 0.70 (0.27-1.77) .20
Convenience foods pattern 0.90 (0.36-2.23) 1.19 (0.49-2.90) 0.80 (0.32-1.98) .80
Total vitamin E, lg/d 0.81 (0.32-2.01) 0.90 (0.36-2.26) 0.54 (0.22-1.34) .23
a-Carotene, lg/d 0.48 (0.20-1.18) 0.49 (0.19-1.24) 0.61 (0.24-1.60) .33
b-Carotene, lg/d 0.57 (0.23-1.42) 0.55 (0.21-1.43) 0.59 (0.22-1.59) .31
Lycopene, lg/d 1.01 (0.39-2.58) 1.09 (0.40-2.97) 0.35 (0.13-0.94) .03c
b-Cryptoxanthin, lg/d 0.30 (0.11-0.81) 0.64 (0.25-1.63) 0.40 (0.15-1.04) .27
Lutein1 zeaxanthin, lg/d 0.67 (0.28-1.64) 0.57 (0.23-1.43) 0.45 (0.17-1.20) .11
Total carotenoids, lg/d 0.42 (0.17-1.06) 0.59 (0.23-1.53) 0.19 (0.23-1.53) .006c
TNF-a: OR (95% CI)d
Pattern/Nutrient Intake Q2 Q3 Q4 Ptrend
Whole foods pattern 0.41 (0.14-1.18) 0.29 (0.09-0.92) 0.19 (0.06-0.64) .008c
Western pattern 0.91 (0.34-2.45) 0.62 (0.21-1.81) 0.63 (0.21-1.83) .31
Convenience foods pattern 1.21 (0.43-3.43) 1.18 (0.42-3.25) 0.44 (0.14-1.33) .16
Total vitamin E, lg/d 0.92 (0.32-2.63) 1.09 (0.38-3.14) 0.76 (0.27-2.16) .69
a-Carotene, lg/d 0.42 (0.15-1.22) 0.60 (0.21-1.72) 0.72 (0.25-2.10) .67
b-Carotene, lg/d 0.36 (0.12-1.05) 0.30 (0.10-0.95) 0.60 (0.20-1.83) .44
Lycopene, lg/d 0.45 (0.15-1.37) 0.99 (0.32-3.11) 0.24 (0.07-0.84) .08
b-Cryptoxanthin, lg/d 0.52 (0.17-1.59) 0.61 (0.21-1.77) 0.69 (0.24-2.02) .67
Lutein1 zeaxanthin, lg/d 0.48 (0.17-1.36) 0.68 (0.25-1.90) 0.31 (0.10-0.99) .09
Total carotenoids, lg/d 0.38 (0.13-1.09) 0.64 (0.22-1.88) 0.22 (0.07-0.72) .04c
IFN-g: OR (95% CI)b
Pattern/Nutrient Intake Q2 Q3 Q4 Ptrend
Whole foods pattern 0.58 (0.23-1.48) 0.40 (0.15-1.10) 0.32 (0.12-0.90) .03c
Western pattern 0.90 (0.37-2.17) 0.75 (0.29-1.92) 1.33 (0.52-3.42) .64
Convenience foods pattern 1.34 (0.53-3.36) 1.59 (0.64-3.94) 0.84 (0.34-2.12) .79
Total vitamin E, lg/d 0.53 (0.21-1.36) 0.32 (0.12-0.84) 0.27 (0.10-0.70) .004c
a-Carotene, lg/d 0.76 (0.31-1.88) 0.79 (0.31-2.01) 0.79 (0.31-2.07) .67
b-Carotene, lg/d 0.87 (0.35-2.20) 0.46 (0.17-1.23) 0.61 (0.22-1.65) .21
Lycopene, lg/d 0.85 (0.33-2.21) 1.17 (0.43-3.21) 0.60 (0.22-1.62) .38
b-Cryptoxanthin, lg/d 0.16 (0.06-0.47) 0.51 (0.20-1.35) 0.27 (0.10-1.35) .14
Lutein1 zeaxanthin, lg/d 1.08 (0.44-2.68) 0.58 (0.23-1.47) 0.56 (0.21-1.49) .14
Total carotenoids, lg/d 0.45 (0.18-1.16) 0.69 (0.26-1.81) 0.29 (0.10-0.78) .04c
Abbreviations: CI, confidence interval; IFN-g, interferon gamma; IL-6, interleukin-6; OR, odds ratio; Q, quartile; TNF-a, tumor necrosis factor alpha.
a The model was adjusted for age, sex, tumor site, cancer stage, smoking, and alcohol problem; ORs were calculated by comparing the upper quartile versus
the lowest quartile (Q1) for each pattern or nutrient intake.
bORs were calculated by comparing higher versus lower cytokine values for cytokines categorized into 3 levels.
cP values< .05 indicate a significant difference.
dORs were calculated by comparing nonzero versus zero values for cytokines categorized into 2 levels.
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observe any significant associations between cytokine lev-
els and serum carotenoids and tocopherols, with the
exception of a-tocopherol and b-cryptoxanthin with
IFN-g. This suggests that other dietary variables that are
highly correlated with dietary carotenoid intakes may be
driving the associations of reported carotenoid intake
with cytokine levels. These could include bioactive com-
pounds present in fruits and vegetables, such as polyphe-
nolic compounds and flavonoids. It has been
demonstrated that flavonoids inhibit NF-jB signaling
and down-regulate the expression of proinflammatory
markers and should be examined in relation to proinflam-
matory cytokines in HNSCC in the future.45
For the current study, we used comprehensive die-
tary and serum data collected from patients and had the
ability to adjust for multiple potential confounding fac-
tors, which strengthened our conclusions. No causal infer-
ences could be made because of the cross-sectional design,
which is a limitation of the study. Random measurement
error in dietary reporting may have led to misclassification
bias. However, such bias is likely to attenuate associations
toward the null.23 Data on additional variables that may
TABLE 5. Multivariable Odds Ratios and 95% Confidence Intervals for Proinflammatory Cytokine Levels by
Quartile of Nutrient Biomarker Levels (n5 151)a
IL-6: OR (95% CI)b
Biomarker, lg/mL Q2 Q3 Q4 Ptrend
a-Tocopherol 0.80 (0.33-1.93) 1.07 (0.44-2.64) 1.21 (0.49-2.98) .56
g-Tocopherol 1.80 (0.74-4.37) 0.92 (0.38-2.21) 1.23 (0.51-2.96) .97
a-Carotene 0.84 (0.34-2.05) 0.97 (0.38-2.48) 0.97 (0.36-2.59) .98
b-Carotene 0.87 (0.35-2.15) 1.48 (0.58-3.75) 1.25 (0.50-3.15) .43
Lycopene 1.02 (0.42-2.48) 0.64 (0.26-1.59) 0.78 (0.30-1.99) .43
b-Cryptoxanthin 0.30 (0.11-0.81) 0.64 (0.25-1.63) 0.40 (0.15-1.04) .27
Lutein 0.83 (0.34-2.02) 0.52 (0.20-1.35) 0.97 (0.38-2.52) .73
Zeaxanthin 0.81 (0.33-1.97) 0.77 (0.31-1.91) 0.60 (0.23-1.52) .29
Total carotenoids 0.63 (0.26-1.55) 1.15 (0.45-2.93) 0.71 (0.27-1.81) .70
TNF-a: OR (95% CI)c
Biomarker, lg/mL Q2 Q3 Q4 Ptrend
a-Tocopherol 1.39 (0.47-4.06) 2.70 (0.90-8.10) 1.92 (0.65-5.69) .28
g-Tocopherol 1.98 (0.61-6.41) 2.10 (0.68-6.50) 1.85 (0.57-6.03) .33
a-Carotene 2.54 (0.73-8.89) 2.44 (0.71-8.33) 1.51 (0.44-5.19) .57
b-Carotene 2.45 (0.75-8.02) 3.31 (0.91-12.06) 1.02 (0.26-3.99) .96
Lycopene 1.28 (0.42-3.88) 0.88 (0.27-2.86) 1.35 (0.41-4.45) .72
b-Cryptoxanthin 2.25 (0.70-7.28) 1.39 (0.44-4.37) 1.18 (0.34-4.06) .92
Lutein 1.73 (0.54-5.53) 2.33 (0.68-7.97) 2.35 (0.71-7.80) .16
Zeaxanthin 1.14 (0.35-3.71) 2.31 (0.76-6.97) 0.80 (0.23-2.77) .88
Total carotenoids 0.79 (0.26-2.41) 1.21 (0.38-3.87) 0.87 (0.26-2.91) .93
IFN-g: OR (95% CI)b
Biomarker, lg/mL Q2 Q3 Q4 Ptrend
a-Tocopherol 0.99 (0.41-2.42) 0.90 (0.35-2.26) 0.62 (0.25-1.57) .03d
g-Tocopherol 2.68 (0.99-7.27) 1.61 (0.62-4.22) 1.39 (0.51-3.78) .90
a-Carotene 1.51 (0.54-4.27) 1.51 (0.54-4.21) 1.20 (0.42-3.40) .76
b-Carotene 0.88 (0.34-2.32) 1.62 (0.55-4.76) 0.91 (0.30-2.78) .91
Lycopene 0.98 (0.38-2.53) 0.60 (0.22-1.68) 1.25 (0.44-3.52) .82
b-Cryptoxanthin 0.94 (0.35-2.48) 0.60 (0.23-1.57) 0.35 (0.12-1.01) .03d
Lutein 1.07 (0.42-2.73) 0.94 (0.34-2.64) 0.73 (0.27-1.99) .51
Zeaxanthin 0.68 (0.26-1.79) 0.72 (0.28-1.85) 0.42 (0.15-1.20) .14
Total carotenoids 0.76 (0.30-1.95) 0.61 (0.22-1.66) 0.53 (0.18-1.54) .23
Abbreviations: CI, confidence interval; IFN-g, interferon gamma; IL-6, interleukin-6; OR, odds ratio; Q, quartile; TNF-a, tumor necrosis factor alpha.
a The model was adjusted for age, sex, tumor site, cancer stage, smoking, and alcohol problem; ORs were calculated by comparing the upper quartile versus
the lowest quartile (Q1) of each biomarker.
bORs were calculated by comparing higher versus lower cytokine values for cytokines categorized into 3 levels.
c ORs were calculated by comparing nonzero versus zero values for cytokines categorized into 2 levels.
dP values< .05 indicate a significant difference.
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have influenced results, such as steroid use or autoimmune
history of patients, were not readily available, which is
study limitation.
In summary, pretreatment diet, particularly a whole
foods dietary pattern and total carotenoid intake, may be
associated with lower systemic inflammation in patients
with newly diagnosed HNSCC, as measured by serum
levels of IL-6, TNF-a, and IFN-g. These associations
may provide mechanistic evidence for our previously
described findings of the association between a whole
foods dietary pattern and prolonged survival.5 The
current results can serve as the basis for translational inter-
vention research in HNSCC populations, in which the
objective is to increase the consumption of foods that are
characteristic of the whole foods dietary pattern and abun-
dant in dietary carotenoids.
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